Peptide sequences and other techniques that relate to RV001 and their use are protected by a family of patents derived from an international patent application (WO2009076966).
Patent application (PCT) filed on 18 December 2008. The table below presents the regions/countries that are covered by the company’s patents/applications and their status in that region. The company is continuously developing its family of patents.
|Region/Country||Status||Expected Patent Expiry*|
|Canada||Pending||(December 2028 if granted)|
* not including any patent term extension/supplementary protection certificate(s) that may be granted